These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of two synthetic ACTH analogues on the metabolism of biogenic amines in the rat brain. Leonard BE Arch Int Pharmacodyn Ther; 1974 Feb; 207(2):242-53. PubMed ID: 4363855 [No Abstract] [Full Text] [Related]
4. Changes of some putative neurotransmitters in human cerebral infarction. Jellinger K; Riederer P; Kothbauer P J Neural Transm Suppl; 1978; (14):31-44. PubMed ID: 39976 [TBL] [Abstract][Full Text] [Related]
5. [Cerebral ischemia and changes in the brain monoamines]. Kogure K No To Shinkei; 1983 Jan; 35(1):33-9. PubMed ID: 6197078 [No Abstract] [Full Text] [Related]
6. [Neurotransmitters in the cerebrospinal fluid (author's transl)]. Takeoka T No To Shinkei; 1981 Sep; 33(9):927-46. PubMed ID: 6172140 [No Abstract] [Full Text] [Related]
7. [Current biochemical conceptions of mental diseases. II. Role of changes in the biogenic amine system in the pathogenesis of affective disorders]. Anokhina IP; Gamaleia NB Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(6):921-30. PubMed ID: 6158209 [No Abstract] [Full Text] [Related]
8. Pharmacological properties of new cyclic derivatives of phenylsuccinimide and their influence on noradrenaline, dopamine, serotonin, 5-hydroxyindoleacetic acid, gamma-aminobutyric acid concentrations and monoaminooxidase activity in animal brains. Chmielewska B Pharmazie; 1984 Apr; 39(4):259-62. PubMed ID: 6204346 [TBL] [Abstract][Full Text] [Related]
9. [Variations of cerebral biogenic amines after injection of 4-butyrolactone]. Nouaille-Degorce J; Riotte M; Barras B; Pegon Y; Cier A C R Seances Soc Biol Fil; 1971; 165(7):1676-81. PubMed ID: 4261929 [No Abstract] [Full Text] [Related]
10. [Biochemical aspects of human behaviour (author's transl)]. Ambrozi L; Birkmayer W; Danielczyk W; Neumayer E; Riederer P Folia Clin Int (Barc); 1973 Sep; 23(9):565-87. PubMed ID: 4616856 [No Abstract] [Full Text] [Related]
11. Concentration of biogenic amines and their metabolites in different parts of brain after experimental cerebral concussion. Kmieciak-Kołada K; Felińska W; Stachura Z; Majchrzak H; Herman ZS Pol J Pharmacol Pharm; 1987; 39(1):47-53. PubMed ID: 2444951 [TBL] [Abstract][Full Text] [Related]
12. [Cerebral metabolic activator (author's transl)]. Ishihara N; Gotoh F No To Shinkei; 1979 Aug; 31(8):739-49. PubMed ID: 40583 [No Abstract] [Full Text] [Related]
13. Further studies on monoamine metabolism in three regions of mouse brain during pregnancy: monoamine metabolite concentrations and the effects of injected hormones. Greengrass PM; Tonge SR Arch Int Pharmacodyn Ther; 1974 Nov; 212(1):48-59. PubMed ID: 4451418 [No Abstract] [Full Text] [Related]
14. Effects of methylmercury on brain biogenic amines in the developing rat pup. Taylor LL; DiStefano V Toxicol Appl Pharmacol; 1976 Dec; 38(3):489-97. PubMed ID: 13517 [No Abstract] [Full Text] [Related]
16. [Biogenic amines to the pathophysiology of involuntary movements and cerebellar ataxia (author's transl)]. Ando K Tanpakushitsu Kakusan Koso; 1981 Aug; 26(11):1772-80. PubMed ID: 6458067 [No Abstract] [Full Text] [Related]
17. The effect of pronounced hypoglycemia on monoamine metabolism in rat brain. Agardh CD; Carlsson A; Linqvist M; Siesjö BK Diabetes; 1979 Sep; 28(9):804-9. PubMed ID: 467805 [No Abstract] [Full Text] [Related]
18. The effect of methiothepin on cerebral monoamine neurons. Lloyd KG; Bartholini G Adv Biochem Psychopharmacol; 1974; 10():305-9. PubMed ID: 4846546 [No Abstract] [Full Text] [Related]
19. The monoamine oxidases of brain: selective inhibition with drugs and the consequences for the metabolism of the biogenic amines. Yang HY; Neff NH J Pharmacol Exp Ther; 1974 Jun; 189(3):733-40. PubMed ID: 4843170 [No Abstract] [Full Text] [Related]
20. Studies on psychotropic drugs. XX. Effects of 1-methyl-5-o-chlorophenyl-7-ethyl-1,2-dihydro-3H-thieno[2,3-e][1,4]diazepin-2-one (Y-6047) on the metabolism of biogenic amines. Nakanishi M; Setoguchi M Arzneimittelforschung; 1972 Nov; 22(11):1914-8. PubMed ID: 4267010 [No Abstract] [Full Text] [Related] [Next] [New Search]